skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Peter,

I am researching some companies in the medical aesthetics space (INMD, CUTR, VERO, AGN, EOLS) and was wondering in this space, what multiple do companies typically trade at from a few different key metrics such as price to sales, P/E ratio, and any other metrics that you feel would be relevant to this space from a valuation perspective? Thanks.
Read Answer Asked by Andrew on June 15, 2020
Q: Please evaluate Novocare as a potential growth stock. Comments I have read are below and it would be great to hear if you see potential for this to rise as we get back to treating "elective" issues.

Unfortunately, the pandemic has delayed enrollment in some clinical trials. But ultimately, this is the only company with a "fourth modality" of cancer treatment beyond surgery, radiation, and chemotherapy — and with no competitors in sight.

Thanks!
Read Answer Asked by Tim on June 15, 2020
Q: It looks like the corona virus numbers in the states are rising. The fears of a second outbreak seem to be happening. Would you be trimming any of your winning positions right now?
Read Answer Asked by sean on June 15, 2020
Q: I'm interested in the idea of green/sustainable agriculture as a theme moving forward. Any stocks or ETFs that could fit the bill? Thanks
Read Answer Asked by Daryl on June 15, 2020
Q: I would to start a position in all 3 of above mentioned stocks, however, based on today,s action I am thinking I should, I love the long term prospects of all 3, and will be a long term holder. Especially the first two, I really like the exposure to the av technology, I think it’s coming sooner than most people think, and I think it will transform many industries, your general thoughts would be most appreciated
Read Answer Asked by John on June 12, 2020
Q: My income portfolio consisting of the above equities has taken quite a beating in the recent market downturn. Except for LB, there has been some recovery in prices, and so far dividends have been maintained. I have some excess cash to deploy, and would like your advice on whether to double down on some on my current investments, or your suggestions for other beaten down income investments. Thank you.
Read Answer Asked by Jean on June 12, 2020
Q: My sons company is using rbc as their rrsp provider for their employees. Would you be able to recommend one canadian, one us and one international ETFs or mutual funds that rbc provides? These will be long term holds. Thanks.
Read Answer Asked by steven on June 12, 2020
Q: This is emailed to Members and also posted on the Home page of the Members' section on our website.
On the home page , I have comments from may 21st only,
Is this right, in view of the answer and ththe question from your member
Thanks
cdj
Read Answer Asked by claude on June 12, 2020
Q: Hi Peter/Ryan, my 20 year old son wants to get into Vanguard ETF's. He has a TFSA stock account and now wants to add a Vanguard ETF. What is your opinion of Vanguard and is there one you would recommend. Thanks, Nick
Read Answer Asked by Nick on June 12, 2020
Q: Can I please get your thoughts on this company.

Thanks
Read Answer Asked by Scott on June 12, 2020
Q: Hi Peter and Ryan.
The market is a bit crazy lately, with many tech companies reaching all time high, as if the covid-19 has never happened. I think there should be good companies that are still worth to buy. I am wondering how you think about the listed three companies (e.g. CAR, EXPE, LUV).

Thank you,
Yiwen
Read Answer Asked by Yiwen on June 12, 2020
Q: I have 8 below US stocks and would like your expert opinion on which stocks are best to hold, sell, or buy more. Does anyone has big DEBTS and how is their management. If you have to sell in which order I should sell. MSFT is about 4% and all others are only 2% of my portfolio.

CRWD, ECL, BYND, FSLY, SONO, NET, SQ. MSFT.

Thanks for the great service.
Read Answer Asked by Hector on June 12, 2020
Q: Hello -
Over the first decade this century emerging markets seemed to do relatively well. Over the last 10 years or so, it appears that relative performance has been much better in the U.S.

Do you believe Emerging Markets represent good value compared to the U.S.? For instance, VWO has a PE ratio of 13, ERUS is about 7, whereas I think the U.S. is somewhere around 18 - you can correct me if I'm wrong. How much affect does a strong USD play in this recent past 10-year performance? Assuming we see a weakening USD, would that be the trigger point for the two mentioned ETF's to outperform the U.S. indices? Obviously stronger oil prices would also likely help ERUS.

What affect would this also have on BNS with it's exposure to Latin America? It's been the weak sister among the big Canadian banks. Would a weaker USD then give the BNS stock price a boost as a result?

Read Answer Asked by James on June 12, 2020